Cantor Fitzgerald Stock Ratings and Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
9/21/2018Cantor FitzgeraldSet Price TargetKindred Biosciences (KIN)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/21/2018Cantor FitzgeraldSet Price TargetCollegium Pharmaceutical (COLL)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/21/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/21/2018Cantor FitzgeraldInitiatesZynerba Pharmaceuticals (ZYNE)Overweight $21.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/21/2018Cantor FitzgeraldInitiatesElectrocore (ECOR)Overweight -> OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
9/21/2018Cantor FitzgeraldInitiatesCatalyst Pharmaceuticals (CPRX)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
9/21/2018Cantor FitzgeraldInitiatesKalvista Pharmaceuticals (KALV)Overweight -> Overweight $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/21/2018Cantor FitzgeraldInitiatesCara Therapeutics (CARA)Overweight -> Overweight $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldInitiatesCatalyst Pharmaceuticals (CPRX)Overweight -> Overweight $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldLowers TargetEagle Pharmaceuticals (EGRX)Overweight -> Buy$81.00 -> $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldInitiatesCytokinetics (CYTK)Overweight -> Overweight $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/21/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldInitiatesAdverum Biotechnologies (ADVM)Overweight -> Overweight $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldSet Price TargetACADIA Pharmaceuticals (ACAD)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldSet Price TargetAVITA Med Ltd/S (AVMXY)Buy $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldSet Price TargetMesoblast (MESO)Buy $23.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldReiteratesAcelRx Pharmaceuticals (ACRX)Buy $6.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldSet Price TargetCorbus Pharmaceuticals (CRBP)Buy $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldInitiatesT2 Biosystems (TTOO)Buy $11.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldInitiatesHTG Molecular Diagnostics (HTGM)Buy $7.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/20/2018Cantor FitzgeraldSet Price TargetNeurocrine Biosciences (NBIX)Buy $150.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/18/2018Cantor FitzgeraldReiteratesMelinta Therapeutics (MLNT)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/18/2018Cantor FitzgeraldReiteratesathenahealth (ATHN)Hold $145.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/17/2018Cantor FitzgeraldSet Price TargetEli Lilly And Co (LLY)Buy $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/17/2018Cantor FitzgeraldReiteratesMarinus Pharmaceuticals (MRNS)Buy $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/17/2018Cantor FitzgeraldReiteratesEvolus (EOLS)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/17/2018Cantor FitzgeraldRaises TargetWellCare Health Plans (WCG)Overweight$292.00 -> $330.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/16/2018Cantor FitzgeraldSet Price TargetAnaptysBio (ANAB)Buy $124.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/14/2018Cantor FitzgeraldSet Price TargetTeva Pharmaceutical Industries (TEVA)Hold $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/14/2018Cantor FitzgeraldReiteratesRevance Therapeutics (RVNC)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/14/2018Cantor FitzgeraldReiteratesAllergan (AGN)Hold $180.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/14/2018Cantor FitzgeraldInitiatesNeurocrine Biosciences (NBIX)Buy $150.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/14/2018Cantor FitzgeraldReiteratesSupernus Pharmaceuticals (SUPN)Buy $56.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/13/2018Cantor FitzgeraldInitiatesAmedisys (AMED)Neutral $117.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/13/2018Cantor FitzgeraldSet Price TargetCorbus Pharmaceuticals (CRBP)Buy$32.00 -> $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/13/2018Cantor FitzgeraldReiteratesHorizon Pharma (HZNP)Buy $21.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/13/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $45.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldInitiatesLHC Group (LHCG)Overweight $117.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldInitiatesAddus Homecare (ADUS)Overweight $77.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldReiteratesCerner (CERN)Buy $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldSet Price TargetKindred Biosciences (KIN)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldSet Price TargetBiohaven Pharmaceutical (BHVN)Buy $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldSet Price TargetPolarityte (COOL)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldReiteratesEvolent Health (EVH)Buy $37.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldDowngradesVital Therapies (VTL)Overweight -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Cantor FitzgeraldReiteratesBausch Health Companies (BHC)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/11/2018Cantor FitzgeraldSet Price TargetEmergent Biosolutions (EBS)Buy $68.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/10/2018Cantor FitzgeraldInitiatesKrystal Biotech (KRYS)Overweight -> Overweight $28.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/10/2018Cantor FitzgeraldReiteratesAcorda Therapeutics (ACOR)Hold $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/10/2018Cantor FitzgeraldRaises TargetQuality Systems (QSII)Overweight -> Overweight$23.00 -> $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/10/2018Cantor FitzgeraldInitiatesBasilea Pharmaceutica (BPMUF)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
9/10/2018Cantor FitzgeraldInitiatesAridis Pharmaceuticals (ARDS)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
9/9/2018Cantor FitzgeraldInitiatesAridis Pharmaceuticals (ARDS)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/9/2018Cantor FitzgeraldSet Price TargetVital Therapies (VTL)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/6/2018Cantor FitzgeraldInitiatesTabula Rasa HealthCare (TRHC)Overweight -> Overweight $99.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/6/2018Cantor FitzgeraldInitiatesMenlo Therapeutics (MNLO)Overweight -> Overweight $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/6/2018Cantor FitzgeraldSet Price TargetArrowhead Pharmaceuticals (ARWR)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/5/2018Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $23.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/6/2018Cantor FitzgeraldInitiatesDeciphera Pharmaceuticals (DCPH)Buy $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/5/2018Cantor FitzgeraldReiteratesDermira (DERM)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/5/2018Cantor FitzgeraldSet Price Targetbluebird bio (BLUE)Sell $122.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/5/2018Cantor FitzgeraldRaises TargetLuxoft (LXFT)Overweight -> Overweight$46.00 -> $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/5/2018Cantor FitzgeraldRaises TargetHealthequity (HQY)Neutral -> Neutral$68.00 -> $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/5/2018Cantor FitzgeraldRaises TargetCoupa Software (COUP)Overweight -> Overweight$67.00 -> $92.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/4/2018Cantor FitzgeraldSet Price TargetCidara Therapeutics (CDTX)Buy $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/4/2018Cantor FitzgeraldSet Price TargetApellis Pharmaceuticals (APLS)Buy $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/4/2018Cantor FitzgeraldInitiatesAnaptysBio (ANAB)Buy $124.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/4/2018Cantor FitzgeraldDowngradesK2M Group (KTWO)Overweight -> Neutral$28.00 -> $27.50LowView Rating Details  Share on Twitter  Share on StockTwits
9/3/2018Cantor FitzgeraldReiteratesLuxoft (LXFT)Overweight -> Buy $46.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/30/2018Cantor FitzgeraldReiteratesK2M Group (KTWO)Overweight -> Buy $28.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/30/2018Cantor FitzgeraldSet Price TargetMesoblast (MESO)Buy $23.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/29/2018Cantor FitzgeraldSet Price TargetEvolus (EOLS)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/28/2018Cantor FitzgeraldSet Price TargetEmergent Biosolutions (EBS)Buy $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/29/2018Cantor FitzgeraldReiteratesACADIA Pharmaceuticals (ACAD)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/28/2018Cantor FitzgeraldSet Price TargetOpiant Pharmaceuticals (OPNT)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/27/2018Cantor FitzgeraldInitiatesAnaptysBio (ANAB)Overweight $124.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/27/2018Cantor FitzgeraldReiteratesZimmer Biomet (ZBH)Buy $150.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/27/2018Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $23.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/27/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $45.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/24/2018Cantor FitzgeraldSet Price TargetEagle Pharmaceuticals (EGRX)Buy $81.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldSet Price TargetGlobal Blood Therapeutics (GBT)Buy $96.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldSet Price Targetbluebird bio (BLUE)Sell $122.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldSet Price TargetUniqure (QURE)Buy $58.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldRaises TargetJack Henry & Associates (JKHY)Overweight -> Overweight$141.00 -> $169.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldInitiatesACADIA Pharmaceuticals (ACAD)Overweight $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldInitiatesReata Pharmaceuticals (RETA)Overweight $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldInitiatesIntra-Cellular Therapies (ITCI)Overweight $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldInitiatesCorcept Therapeutics (CORT)Neutral $17.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldInitiatesBiohaven Pharmaceutical (BHVN)Overweight $55.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Cantor FitzgeraldInitiatesAcorda Therapeutics (ACOR)Neutral $32.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/22/2018Cantor FitzgeraldDowngradesAetna (AET)Overweight -> Neutral $202.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/22/2018Cantor FitzgeraldInitiatesDeciphera Pharmaceuticals (DCPH)Overweight $53.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/22/2018Cantor FitzgeraldInitiatesHalozyme Therapeutics (HALO)Overweight $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/22/2018Cantor FitzgeraldInitiatesNeurocrine Biosciences (NBIX)Overweight $150.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/22/2018Cantor FitzgeraldInitiatesVanda Pharmaceuticals (VNDA)Neutral $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/22/2018Cantor FitzgeraldInitiatesAlder Biopharmaceuticals (ALDR)Neutral $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/21/2018Cantor FitzgeraldReiteratesJack Henry & Associates (JKHY)Buy $141.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/21/2018Cantor FitzgeraldReiteratesVocera Communications (VCRA)Buy $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/20/2018Cantor FitzgeraldInitiatesVital Therapies (VTL)Overweight $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/17/2018Cantor FitzgeraldReiteratesCastlight Health (CSLT)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/17/2018Cantor FitzgeraldSet Price TargetAbeona Therapeutics (ABEO)Buy $36.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/17/2018Cantor FitzgeraldSet Price TargetEvolus (EOLS)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/15/2018Cantor FitzgeraldReiteratesOptiNose (OPTN)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
8/16/2018Cantor FitzgeraldReiteratesHealth Insurance Innovations (HIIQ)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/16/2018Cantor FitzgeraldReiteratesTeva Pharmaceutical Industries (TEVA)Hold $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/14/2018Cantor FitzgeraldSet Price TargetOptiNose (OPTN)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/14/2018Cantor FitzgeraldRaises TargetTherapeuticsMD (TXMD)Overweight -> Overweight$26.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/13/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/11/2018Cantor FitzgeraldReiteratesAbeona Therapeutics (ABEO)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/11/2018Cantor FitzgeraldSet Price TargetAurinia Pharmaceuticals (AUPH)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/11/2018Cantor FitzgeraldSet Price TargetUniqure (QURE)Buy $58.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesBausch Health Companies (BHC)OverweightN/AView Rating Details  Share on Twitter  Share on StockTwits
8/10/2018Cantor FitzgeraldSet Price TargetTherapeuticsMD (TXMD)Buy $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/10/2018Cantor FitzgeraldRaises TargetVirtusa (VRTU)Overweight -> Overweight$60.00 -> $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/10/2018Cantor FitzgeraldRaises TargetR1 RCM (RCM)Overweight -> Overweight$10.00 -> $11.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/10/2018Cantor FitzgeraldReiteratesEnvision Healthcare (EVHC)Hold $46.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/10/2018Cantor FitzgeraldRaises TargetWorldpay (WP)Overweight -> Overweight$92.00 -> $100.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldSet Price TargetOpiant Pharmaceuticals (OPNT)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/10/2018Cantor FitzgeraldReiteratesCorium International (CORI)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldReiteratesSpero Therapeutics (SPRO)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldReiteratesBioDelivery Sciences International (BDSI)Buy $4.50MediumView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldReiteratesFive Star Senior Living (FVE)Overweight -> Buy$3.00 -> $2.50MediumView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldReiteratesCymaBay Therapeutics (CBAY)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldReiteratesUnitedHealth Group (UNH)Buy $300.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldReiteratesKindred Biosciences (KIN)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldReiteratesAmneal Pharmaceuticals (AMRX)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldReiteratesLTC Properties (LTC)Overweight -> Buy$45.00 -> $46.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldSet Price TargetMomenta Pharmaceuticals (MNTA)Hold $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $23.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldSet Price TargetEmergent Biosolutions (EBS)Buy $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldSet Price TargetPerrigo (PRGO)Buy $107.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldRaises TargetWright Medical Group (WMGI)Overweight -> Overweight$30.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldLowers TargetDXC Technology (DXC)Neutral -> Neutral$97.00 -> $87.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldLowers TargetCollegium Pharmaceutical (COLL)Overweight -> Overweight$40.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesArrowhead Pharmaceuticals (ARWR)Overweight $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Cantor FitzgeraldReiteratesAxoGen (AXGN)Buy $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesCidara Therapeutics (CDTX)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesRigel Pharmaceuticals (RIGL)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldInitiatesPacific Biosciences of California (PACB)Overweight $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldSet Price TargetSupernus Pharmaceuticals (SUPN)Buy $56.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesMylan (MYL)Hold $41.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesProthena (PRTA)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesCorbus Pharmaceuticals (CRBP)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesHeron Therapeutics (HRTX)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldSet Price TargetHorizon Pharma (HZNP)Buy $21.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldSet Price TargetEndo International (ENDP)Hold $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesNeos Therapeutics (NEOS)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldRaises TargetNational Health Investors (NHI)Neutral -> Neutral$75.00 -> $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesGenpact (G)Buy $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldSet Price TargetStrongbridge Biopharma (SBBP)Overweight -> Buy$14.00 -> $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldLowers TargetGW Pharmaceuticals PLC- (GWPH)Overweight$235.00 -> $211.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldSet Price TargetJazz Pharmaceuticals (JAZZ)Buy $203.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldSet Price TargetGalmed Pharmaceuticals (GLMD)Buy $59.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldRaises TargetApellis Pharmaceuticals (APLS)Overweight -> Buy$52.00 -> $53.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldSet Price TargetOcular Therapeutix (OCUL)Buy $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldSet Price TargetBellicum Pharmaceuticals (BLCM)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldReiteratesGlobal Blood Therapeutics (GBT)Buy $96.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Cantor FitzgeraldSet Price TargetMarinus Pharmaceuticals (MRNS)Buy $19.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldReiteratesOpko Health (OPK)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldSet Price TargetArrowhead Pharmaceuticals (ARWR)Buy$13.00 -> $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldReiteratesGenesis Healthcare (GEN)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldSet Price TargetANI Pharmaceuticals (ANIP)Overweight -> Buy$85.00 -> $74.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldReiteratesBausch Health Companies (BHC)Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldInitiatesOptiNose (OPTN)Overweight $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldInitiatesHCP (HCP)Neutral $28.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldReiteratesMallinckrodt (MNK)Buy $42.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldSet Price TargetEagle Pharmaceuticals (EGRX)Buy $81.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldRaises TargetOrthofix Medical (OFIX)Overweight $66.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Cantor FitzgeraldReiteratesSpark Therapeutics (ONCE)Buy $103.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018Cantor FitzgeraldReiteratesDynavax Technologies (DVAX)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018Cantor FitzgeraldReiteratesOmega Healthcare Investors (OHI)Buy $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018Cantor FitzgeraldRaises TargetHMS (HMSY)Neutral -> Neutral$19.00 -> $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018Cantor FitzgeraldSet Price Targetbluebird bio (BLUE)Sell $122.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018Cantor FitzgeraldReiteratesMelinta Therapeutics (MLNT)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018Cantor FitzgeraldRaises TargetMsci (MSCI)Overweight $192.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018Cantor FitzgeraldReiteratesAMAG Pharmaceuticals (AMAG)Neutral -> Hold$17.00 -> $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018Cantor FitzgeraldReiteratesGlobal Payments (GPN)Buy $136.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesPhysicians Realty Trust (DOC)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesAllscripts Healthcare Solutions (MDRX)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesEmergent Biosolutions (EBS)Buy $62.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesAcelRx Pharmaceuticals (ACRX)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesCerus (CERS)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesIntra-Cellular Therapies (ITCI)Buy $28.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldSet Price TargetTeva Pharmaceutical Industries (TEVA)Hold $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldSet Price TargetRevance Therapeutics (RVNC)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesGlobal Blood Therapeutics (GBT)Buy $96.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldSet Price TargetEvolus (EOLS)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesMarinus Pharmaceuticals (MRNS)Buy $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldSet Price TargetSpring Bank Pharmaceuticals (SBPH)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldSet Price TargetIntercept Pharmaceuticals (ICPT)Hold $69.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesAetna (AET)Buy $202.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesExlService (EXLS)Buy $71.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesEPAM Systems (EPAM)Buy $139.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldReiteratesParatek Pharmaceuticals (PRTK)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Cantor FitzgeraldSet Price TargetZoetis (ZTS)Buy $98.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/1/2018Cantor FitzgeraldReiteratesCross Country Healthcare (CCRN)Neutral -> Hold$11.00 -> $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/1/2018Cantor FitzgeraldReiteratesTeladoc (TDOC)Hold $52.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/1/2018Cantor FitzgeraldSet Price TargetTheravance Biopharma (TBPH)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/1/2018Cantor FitzgeraldInitiatesArrowhead Pharmaceuticals (ARWR)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/1/2018Cantor FitzgeraldRaises TargetWellCare Health Plans (WCG)Overweight $292.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/1/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/1/2018Cantor FitzgeraldReiteratesFiserv (FISV)Hold $73.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/1/2018Cantor FitzgeraldRaises TargetFidelity National Information Servcs (FIS)Overweight $117.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/31/2018Cantor FitzgeraldReiteratesNuVasive (NUVA)Hold $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/31/2018Cantor FitzgeraldSet Price TargetApellis Pharmaceuticals (APLS)Buy $52.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/31/2018Cantor FitzgeraldRaises TargetFirst Data (FDC)Neutral $23.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/31/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $45.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/31/2018Cantor FitzgeraldSet Price TargetShire (SHPG)Buy $222.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/30/2018Cantor FitzgeraldReiteratesSeaSpine (SPNE)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/30/2018Cantor FitzgeraldReiteratesThe Ensign Group (ENSG)Buy $42.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/30/2018Cantor FitzgeraldReiteratesHealth Insurance Innovations (HIIQ)Buy $60.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/30/2018Cantor FitzgeraldSet Price TargetTherapeuticsMD (TXMD)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/30/2018Cantor FitzgeraldSet Price TargetOpiant Pharmaceuticals (OPNT)Buy $32.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/30/2018Cantor FitzgeraldRaises TargetZimmer Biomet (ZBH)Overweight -> Overweight$140.00 -> $150.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/30/2018Cantor FitzgeraldSet Price TargetAcorda Therapeutics (ACOR)Hold $17.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/27/2018Cantor FitzgeraldReiteratesVentas (VTR)Hold $56.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/27/2018Cantor FitzgeraldReiteratesR1 RCM (RCM)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/27/2018Cantor FitzgeraldSet Price TargetZoetis (ZTS)Buy $98.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/27/2018Cantor FitzgeraldReiterateseHealth (EHTH)Overweight $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/27/2018Cantor FitzgeraldReiteratesMastercard (MA)Overweight $237.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/26/2018Cantor FitzgeraldReiteratesOmnicell (OMCL)Buy $63.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/26/2018Cantor FitzgeraldInitiatesUniqure (QURE)Overweight $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/26/2018Cantor FitzgeraldRaises TargetVisa (V)Overweight $160.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/26/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $180.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/26/2018Cantor FitzgeraldRaises TargetPaypal (PYPL)Average -> Overweight $98.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/25/2018Cantor FitzgeraldSet Price TargetBiogen (BIIB)Hold $293.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/25/2018Cantor FitzgeraldReiteratesIntegra Lifesciences (IART)Hold $59.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/25/2018Cantor FitzgeraldSet Price TargetCorbus Pharmaceuticals (CRBP)Buy $32.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/25/2018Cantor FitzgeraldSet Price TargetPolarityte (COOL)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/25/2018Cantor FitzgeraldRaises TargetCentene (CNC)Overweight -> Overweight$135.00 -> $145.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/25/2018Cantor FitzgeraldReiteratesAnthem (ANTM)Buy $275.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/25/2018Cantor FitzgeraldRaises TargetHorizon Pharma (HZNP)Overweight $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/25/2018Cantor FitzgeraldRaises TargetEli Lilly And Co (LLY)Overweight -> Overweight$100.00 -> $110.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/25/2018Cantor FitzgeraldRaises TargetStryker (SYK)Neutral -> Neutral$170.00 -> $175.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/24/2018Cantor FitzgeraldSet Price TargetEli Lilly And Co (LLY)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/23/2018Cantor FitzgeraldReiteratesIntra-Cellular Therapies (ITCI)Buy $28.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/23/2018Cantor FitzgeraldReiteratesHealthStream (HSTM)Hold $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/23/2018Cantor FitzgeraldSet Price TargetEvolus (EOLS)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/23/2018Cantor FitzgeraldInitiatesKindred Biosciences (KIN)Overweight $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/23/2018Cantor FitzgeraldSet Price TargetEndo International (ENDP)Hold $12.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/23/2018Cantor FitzgeraldReiteratesSyntel (SYNT)Hold $41.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/20/2018Cantor FitzgeraldReiteratesHCA Healthcare (HCA)Buy $115.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/20/2018Cantor FitzgeraldReiteratesCerus (CERS)Overweight -> Reduce $9.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/19/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $180.00LowView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Friday at 09:05 PM ET.

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:  0.9 out of 5 (star star)
Outperform Votes:  3,102 (Vote Outperform)
Underperform Votes:  13,576 (Vote Underperform)
Total Votes:  16,678
MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel